Immune adverse events (irAEs) with adjuvant ipilimumab in melanoma, use of immunosuppressants and association with outcome: ECOG-ACRIN E1609 study analysis.
Tarhini AA, Kang N, Lee SJ, Hodi FS, Cohen GI, Hamid O, Hutchins LF, Sosman JA, Kluger HM, Eroglu Z, Koon HB, Lawrence DP, Kendra KL, Minor DR, Lee CB, Albertini MR, Flaherty LE, Petrella TM, Streicher H, Sondak VK, Kirkwood JM.
Tarhini AA, et al. Among authors: petrella tm.
J Immunother Cancer. 2021 May;9(5):e002535. doi: 10.1136/jitc-2021-002535.
J Immunother Cancer. 2021.
PMID: 33963015
Free PMC article.
Clinical Trial.